Stocks of medical technology firms manufacturing and marketing health-care products have had a mixed year. In the wake of the outbreak of the coronavirus pandemic, elective surgeries have been delayed or even cancelled in many countries.
As the rollout of vaccines into 2021 brings more normality to our lives, as well as to the healthcare sector, two UK-headquartered global companies may pique investor interest: Smith & Nephew (LON:), (NYSE:) and ConvaTec (LON:), (OTC:).
We believe the long-term growth possibilities for each remains upbeat in a post-COVID world. According to metrics from the United Nations:
“Virtually every country in the world is experiencing growth in the number and proportion of older persons in their population… [B]y 2050, one in six people in the world will be over age 65 (16%), up from one in 11 in 2019 (9%).”
Similarly, the UK’s Office for National Statistics suggests:
“In 50 years’ time, there